4526 · Riken Vitamin Co., Ltd. · Financials
Market Cap
104.54B JPY
Shares
28.56M
Volume · Nov 13
99.5K
Avg daily vol (3M)
94.73K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
96.3B
+0.8%
FY2026
Net Income
7.04B
-25.1%
FY2026
Gross Margin
30.91%
-1.8pp
FY2026
Operating Margin
7.17%
-2pp
FY2026
Operating Cash Flow
5.96B
-24.4%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| JPY | 96.3B | 95.58B | 91.48B | 88.75B | 79.23B |
| JPY | 66.53B | 64.31B | 61.6B | 61.51B | 53.67B |
| JPY | 29.77B | 31.27B | 29.89B | 27.24B | 25.56B |
| JPY | 6.9B | 8.72B | 9.37B | 7.16B | 5.84B |
| JPY | 10.24B | 12.71B | 11.91B | 7.86B | 20.31B |
| JPY | 3.2B | 3.31B | 3.15B | 1.44B | -1.29B |
| JPY | 7.04B | 9.39B | 8.76B | 6.41B | 21.58B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 11.18B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.